Shuangbing Xu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Signaling Pathway

Radiation Induced

Top Venues

Cell death discovery

Cell death & disease

Cell death and differentiation

This page only lists publications with an associated author ORCID identifier.

Publications

Yunshang Chen, Yun Zhou, Xue Feng, Zilong Wu, Yongqiang Yang, Xinrui Rao, Rui Zhou, Rui Meng, Xiaorong Dong, Shuangbing Xu, Sheng Zhang, Gang Wu, Xiaohua Jie
Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis. Cell death & disease 15 (1) (2024)
Yunshang Chen, Yun Zhou, Xue Feng, Zilong Wu, Yongqiang Yang, Xinrui Rao, Rui Zhou, Rui Meng, Xiaorong Dong, Shuangbing Xu, Sheng Zhang, Gang Wu, Xiaohua Jie
Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis. Cell death & disease 15 (1) (2024)
Yunshang Chen, Yun Zhou, Xue Feng, Zilong Wu, Yongqiang Yang, Xinrui Rao, Rui Zhou, Rui Meng, Xiaorong Dong, Shuangbing Xu, Sheng Zhang, Gang Wu, Xiaohua Jie
Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis. Cell death & disease 15 (1) (2024)
Yunshang Chen, Yun Zhou, Xue Feng, Zilong Wu, Yongqiang Yang, Xinrui Rao, Rui Zhou, Rui Meng, Xiaorong Dong, Shuangbing Xu, Sheng Zhang, Gang Wu, Xiaohua Jie
Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis. Cell death & disease 15 (1) (2024)
Zhen Zeng, Zixuan Li, Jun Xue, Huichan Xue, Zhiwei Liu, Wenxuan Zhang, Hongli Liu, Shuangbing Xu
KDM4C silencing inhibits cell migration and enhances radiosensitivity by inducing CXCL2 transcription in hepatocellular carcinoma. Cell death discovery 9 (1) (2023)
Zhen Zeng, Zixuan Li, Jun Xue, Huichan Xue, Zhiwei Liu, Wenxuan Zhang, Hongli Liu, Shuangbing Xu
KDM4C silencing inhibits cell migration and enhances radiosensitivity by inducing CXCL2 transcription in hepatocellular carcinoma. Cell death discovery 9 (1) (2023)
Zhen Zeng, Zixuan Li, Jun Xue, Huichan Xue, Zhiwei Liu, Wenxuan Zhang, Hongli Liu, Shuangbing Xu
KDM4C silencing inhibits cell migration and enhances radiosensitivity by inducing CXCL2 transcription in hepatocellular carcinoma. Cell death discovery 9 (1) (2023)
Zhen Zeng, Zixuan Li, Jun Xue, Huichan Xue, Zhiwei Liu, Wenxuan Zhang, Hongli Liu, Shuangbing Xu
KDM4C silencing inhibits cell migration and enhances radiosensitivity by inducing CXCL2 transcription in hepatocellular carcinoma. Cell death discovery 9 (1) (2023)
Xiaohua Jie, Yunshang Chen, Ye Zhao, Xijie Yang, Yingzhuo Xu, Jian Wang, Rui Meng, Sheng Zhang, Xiaorong Dong, Tao Zhang, Kunyu Yang, Shuangbing Xu, Gang Wu
Targeting KDM4C enhances CD8 + T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer. Journal for immunotherapy of cancer 10 (2) (2022)
Xiaohua Jie, William Pat Fong, Rui Zhou, Ye Zhao, Yingchao Zhao, Rui Meng, Sheng Zhang, Xiaorong Dong, Tao Zhang, Kunyu Yang, Gang Wu, Shuangbing Xu
USP9X-mediated KDM4C deubiquitination promotes lung cancer radioresistance by epigenetically inducing TGF-β2 transcription. Cell death and differentiation 28 (7) (2021)
Yanwei Lu, Xudong Li, Hongli Liu, Jun Xue, Zhen Zeng, Xiaorong Dong, Tao Zhang, Gang Wu, Kunyu Yang, Shuangbing Xu
β-Trcp and CK1δ-mediated degradation of LZTS2 activates PI3K/AKT signaling to drive tumorigenesis and metastasis in hepatocellular carcinoma. Oncogene 40 (7) (2021)
Yumei Huang, Xijie Yang, Yanwei Lu, Ye Zhao, Rui Meng, Sheng Zhang, Xiaorong Dong, Shuangbing Xu, Gang Wu
UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance. Cell death and differentiation 28 (2) (2020)